European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) Recommends Expanded Use of Janssen's (JNJ) Darzalex + Celgene's (CELG) Revlimid and Takeda's (TKPYY) Velcade for Multiple Myeloma

Source Link:

http://seekingalpha.com/pr/16752719-chmp-issues-positive-opinion-recommending-darzalex-daratumumab-relapsed-refractory-multiple